Q2 EARNINGS: Biomet disappoints, but not all doom and gloom for ortho market
This article was originally published in Clinica
Executive Summary
Biomet reported flat sales in its hip and knee franchises during its second fiscal quarter: but although this could be another sign of a slowdown in the large joint reconstruction market, there are other factors at play, according to analysts.